Institution
University of Tokyo
Education•Tokyo, Japan•
About: University of Tokyo is a education organization based out in Tokyo, Japan. It is known for research contribution in the topics: Population & Gene. The organization has 134564 authors who have published 337567 publications receiving 10178620 citations. The organization is also known as: Todai & Universitas Tociensis.
Topics: Population, Gene, Catalysis, Magnetic field, Galaxy
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, a gapless phase between the spin Hall and the insulator phases in 3D was investigated in inversion-asymmetric systems, and it was shown that the existence of such a phase stems from the topological nature of gapless points (diabolical points) in three dimensions, but not in 2D.
Abstract: Phase transitions between the quantum spin Hall (QSH) and the insulator phases in three dimensions (3D) are studied. We find that in inversion-asymmetric systems there appears a gapless phase between the QSH and insulator phases in 3D which is in contrast with the 2D case. Existence of this gapless phase stems from a topological nature of gapless points (diabolical points) in 3D, but not in 2D.
979 citations
••
TL;DR: Two studies demonstrate that blocking IL-23 or its downstream factors IL-17 and IL-6, but not the IL-12/IFN-gamma pathways, can significantly suppress disease development in animal models of inflammatory bowel disease and MS.
Abstract: IL-23 induces the differentiation of naive CD4(+) T cells into highly pathogenic helper T cells (Th17/Th(IL-17)) that produce IL-17, IL-17F, IL-6, and TNF-alpha, but not IFN-gamma and IL-4. Two studies in this issue of the JCI demonstrate that blocking IL-23 or its downstream factors IL-17 and IL-6, but not the IL-12/IFN-gamma pathways, can significantly suppress disease development in animal models of inflammatory bowel disease and MS (see the related articles beginning on pages 1310 and 1317). These studies suggest that the IL-23/IL-17 pathway may be a novel therapeutic target for the treatment of chronic inflammatory diseases.
979 citations
••
TL;DR: In this paper, the historical development of water-splitting photocatalysts has been described and a review article describes the development of active water splitting materials has relied on both photochemical and cocatalytic materials.
Abstract: Overall water splitting to produce H 2 and O 2 over a semiconductor photocatalyst using solar energy is a promising process for the large-scale production of clean, recyclable H 2 . Numerous attempts have been made to develop photocatalysts that function under visible-light irradiation to efficiently utilize solar energy. In general, overall water splitting over a photocatalyst particle can be achieved by modifying the photocatalyst with a suitable cocatalyst to provide an active redox site. Therefore, the development of active photocatalytic materials has relied on both photocatalysts and cocatalysts. This review article describes the historical development of water-splitting photocatalysts.
977 citations
••
TL;DR: A new genus Burkholderia is proposed for the RNA homology group II of genus Pseudomonas and seven species in this group were transfered to the new genus.
Abstract: Based on the 16S rRNA sequences, DNA-DNA homology values, cellular lipid and fatty acid composition, and phenotypic characteristics, a new genus Burkholderia is proposed for the RNA homology group II of genus Pseudomonas. Seven species in this group were transfered to the new genus. Thus seven new combinations, Burkholderia cepacia (Palleroni and Holmes 1981), Burkholderia mallei (Zopf 1885), Burkholderia pseudomallei (Whitmore 1913), Burkholderia caryophylli (Burkholder 1942), Burkholderia gladioli (Severini 1913), Burkholderia pickettii (Ralston et al 1973) and Burkholderia solanacearum (Smith 1896) were proposed.
975 citations
••
TL;DR: Polymeric micelles are nanotechnology-based carrier systems that might exert the activity of potent bioactive compounds in a site-directed manner, ensuring their effectiveness and safety in the clinical use.
973 citations
Authors
Showing all 135252 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ronald C. Kessler | 274 | 1332 | 328983 |
Donald P. Schneider | 242 | 1622 | 263641 |
George M. Whitesides | 240 | 1739 | 269833 |
Jing Wang | 184 | 4046 | 202769 |
Tadamitsu Kishimoto | 181 | 1067 | 130860 |
Yusuke Nakamura | 179 | 2076 | 160313 |
Dennis J. Selkoe | 177 | 607 | 145825 |
David L. Kaplan | 177 | 1944 | 146082 |
D. M. Strom | 176 | 3167 | 194314 |
Masayuki Yamamoto | 171 | 1576 | 123028 |
Krzysztof Matyjaszewski | 169 | 1431 | 128585 |
Yang Yang | 164 | 2704 | 144071 |
Qiang Zhang | 161 | 1137 | 100950 |
Kenji Kangawa | 153 | 1117 | 110059 |
Takashi Taniguchi | 152 | 2141 | 110658 |